Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

XENOVIEW

XENON XE-129 HYPERPOLARIZED

Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview XENOVIEW is listed in Drugs@FDA under application 214375 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient XENON XE-129 HYPERPOLARIZED Form and strength GAS;INHALATION - N/A Sponsor POLAREAN Submission history Latest submission status date: 2025-05-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview XENOVIEW is listed in Drugs@FDA under application 214375 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient XENON XE-129 HYPERPOLARIZED Form and strength GAS;INHALATION - N/A Sponsor POLAREAN Submission history Latest submission status date: 2025-05-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.